Abbott Toxicology - Alere is now Abbott This system connects you with tools and information to efficiently and effectively manage your substance abuse testing program with Alere Toxicology Services, Inc , a wholly owned subsidiary of Abbott
Lab Supply Request Form - Alere Toxicology Lab Supply Request FormIf you are an existing customer with an active account that needs supplies, please complete our online request form below To best serve you, please use information that is associated with your account contract and ensure that all fields are completed Once submitted, a representative will contact you to finalize your request Please note that completing this form does
Alere - Wikipedia In 2010, Alere launched the Alere CD4 analyser, the world's first to provide absolute CD4 results at the Point of Care, making the management of HIV patients easier and more effective
Alere Inc. - LinkedIn About us Alere is now Abbott! Abbott is a global healthcare leader that helps people live more fully at all stages of life
Microsoft Word - Abbott. Alere Fact Sheet. v8 Abbott has agreed to acquire Alere (NYSE: ALR), the Massachusetts-based point of care testing company, significantly advancing its diagnostics presence and leadership
Rapid Diagnostics | Abbott Point of Care Abbott Rapid Diagnostics (formally Alere) and Point of Care Testing (POCT) Find out more about our best-in-class products and solutions
Alere Toxicology Service, Inc. | Alere Drug Testing Information In 2010, Kroll Laboratory Specialists, Inc was changed to its current name when it became a subsidiary of Alere, Inc , a global leader in the diagnostic test device and service provider industry
Alere | Company Overview News - Forbes Alere, Inc develops, manufactures and markets consumer and professional medical diagnostic products The company's products and services focus on cardiology, infectious disease, women's health
Drug Alcohol Testing Services | Abbott Toxicology Abbott is a world leader in Toxicology SolutionsThe Industry dynamics for drugs and alcohol are changing in response to the shifting narrative that surrounds substance abuse testing resulting in uncertainty and the need to embrace change